Until the full potential of genetic data is realized, clinicians can still personalize treatment of their patients using the
tried-and-true methods of family history taking, rational treatment choice, side-effect monitoring, and switching patients
to other treatments when indicated by side effects or treatment failure. Harvey noted, for instance, that recommendations
from APA and the American Diabetes Association to regularly monitor patients receiving antipsychotic medication for weight
gain and metabolic syndrome have not produced a measurable change in clinical practice; rates of monitoring have remained
virtually unchanged since before the release of those guidelines.